Concepedia

DURATION-5: Exenatide Once Weekly Resulted in Greater Improvements in Glycemic Control Compared with Exenatide Twice Daily in Patients with Type 2 Diabetes

Thomas Blevins, John Pullman, Jaret Malloy, Ping Yan, Kristin Taylor, Christine T. Schulteis, Michael Trautmann, Lisa A. Porter

The Journal of Clinical Endocrinology & Metabolism · 2011 · 442 citations · 34 references

DOI Full text

Open access

Abstract

Continuous glucagon-like peptide-1 receptor agonism with ExQW resulted in superior glycemic control, with less nausea, compared with ExBID in patients with type 2 diabetes. Both groups lost weight.

References

34

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

The Lancet · 1998 · 19.9K citations

Metabolic Syndrome, Diabetes Management, Insulin Management +9

A sharper Bonferroni procedure for multiple tests of significance

Yosef Hochberg · Biometrika · 1988 · 4.7K citations

Israel Search, December 1988, Multiple Tests +14

Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy

David M. Nathan, John B. Buse, Mayer B. Davidson et al. · Diabetes Care · 2008 · 3.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Health Policy +14

Standards of Medical Care in Diabetes—2010

Diabetes Care · 2009 · 3.4K citations · Full text

Diabetes Management, Health Policy, Diabetes +2

Effects of Exenatide (Exendin-4) on Glycemic Control and Weight Over 30 Weeks in Metformin-Treated Patients With Type 2 Diabetes

Ralph A. DeFronzo, Robert E. Ratner, Jenny Han et al. · Diabetes Care · 2005 · 1.5K citations